Figuring out how long it's taken the Multidisciplinary Association for Psychedelic Studies' (MAPS) application to reach the FDA’s desk all depends on when you start counting. The organization was ...

A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of ...

On Sept. 13, information about the results of a new Phase 3 Trial of MDMA-assisted therapy for PTSD treatment was published by the Multidisciplinary Association for Psychedelic Substances (MAPS). The ...

SANTA CRUZ, CA (WJZ) --The U.S. Food and Drug Administration recently approved an expansion of a trial that allows researchers to see how MDMA could help people with posttraumatic stress disorder. The ...

Numinus Wellness NUMIF with support from the Multidisciplinary Association for Psychedelic Studies (MAPS) will utilize Optimi Health’s OPTHF Good Manufacturing Practice (GMP)-compliant MDMA to conduct ...

In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (OTC:NUMIF) has taken steps to get out in front of the curve. Today, ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA sign Sarah Silbiger/Getty Images MDMA, the popular psychedelic-like drug also called "ecstasy" or "molly," has a storied ...

MAPS Public Benefit Corp. filed an application on Tuesday with the U.S. Food and Drug Administration to approve the psychedelic drug MDMA — also known as Ecstasy — in combination with therapy to treat ...

The Multidisciplinary Association for Psychedelic Studies, a nonprofit pioneer in the movement to legalize psychedelic drugs, is strapped for cash and turning to the market for a lifeline. MAPS is ...